Guidant Wealth Advisors’s Merck MRK Stock Holding History

Guidant Wealth Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$46K	Buy	573 +105	+22%	+$8.41K	0.02%	177
2019 Q2	$37K	Buy	468 +104	+29%	+$7.96K	0.01%	191
2019 Q1	$29K	Buy	364 +50	+16%	+$3.74K	0.01%	203
2018 Q4	$22K	Sell	314 -50	-14%	-$3.53K	0.01%	160
2018 Q3	$24K	Hold	364	–	–	0.01%	113
2018 Q2	$20K	Buy	364 +50	+16%	+$2.82K	0.01%	116
2018 Q1	$15K	Hold	314	–	–	0.01%	131
2017 Q4	$16K	Sell	314 -266	-46%	-$14.7K	0.01%	129
2017 Q3	$35K	Hold	580	–	–	0.02%	86
2017 Q2	$34K	Buy	580 +266	+85%	+$16.2K	0.02%	128
2017 Q1	$19K	Hold	314	–	–	0.01%	140
2016 Q4	$18K	Hold	314	–	–	0.01%	130
2016 Q3	$19K	Buy	+314	New	+$18.4K	0.01%	124

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Guidant Wealth Advisors's MRK Position: Q3 2019 in Review

Guidant Wealth Advisors increased its Merck (MRK) stake by 22% in Q3 2019, buying an estimated $8.41K and bringing the position to 573 shares worth $46K. The position accounts for 0.02% of the portfolio, ranked #177.

Guidant Wealth Advisors first reported a position in MRK in Q3 2016 and has held it in 13 quarters since. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

Guidant Wealth Advisors held 573 shares of Merck worth $46K as of Q3 2019.
Guidant Wealth Advisors bought 105 Merck shares in Q3 2019, an estimated $8.41K.
Merck made up 0.02% of Guidant Wealth Advisors's portfolio in Q3 2019, its #177 holding.
Guidant Wealth Advisors first reported a position in Merck in Q3 2016 and has held it in 13 quarters since.
2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Guidant Wealth Advisors's 13F filing for Q3 2019, filed 16 Oct 2019.